Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Immatics
Company

Immatics

Tracked across 1 events · 8 articles · First seen Apr 17, 2026 · Last active Apr 17, 2026

Sentiment
80
Attention
6
Events
1
Relationships
3
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
6 80
Tech
Immatics' PRAME TCR Therapy Induces Remission in Pediatric Nephroblastoma
Immatics provided the PRAME-directed TCR for an experimental treatment that resulted in deep remission for a pediatric patient with advanced nephroblastoma. This success reinforces the potential of their PRAME-directed cell therapies and supports further clinical evaluation, which could significantly boost the company's market position and stock value.
Apr 17, 2026 · 8 articles
Key Actions (2)
100 Immatics provided PRAME-directed TCR for experimental treatment Hopp Children s Cancer Center HeidelbergImmatics' PRAME TCR...
80 Immatics announced abstract acceptance for presentation American Association for Cancer ResearchImmatics' PRAME TCR...
Relationships (3)
Cedrik Britten Chief Medical Officer ↔ Immatics Cedrik Britten is the Chief Medical Officer at Immatics.
Hopp Children s Cancer Center Heidelberg ↔ Immatics Unknown
Christian M. Seitz ↔ Immatics Unknown
NEWSDESK
Track Immatics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.